Qube Research & Technologies (QRT)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$930K Sell
4,400
-1,100
-20% -$237K ﹤0.01% 2526
2025
Q4
$1.13M Buy
+5,500
New +$1.04M ﹤0.01% 2502
2023
Q4
Sell
-2,900
Closed -$252K 4365
2023
Q3
$252K Buy
+2,900
New +$262K ﹤0.01% 2314

Other funds holding CAH

Qube Research & Technologies (QRT)'s CAH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Cardinal Health (CAH) stake by 3.3% in Q1 2026, selling an estimated $7.5M and leaving 1,012,309 shares worth $214M. The position accounts for 0.24% of the portfolio, ranked #85.

Qube Research & Technologies (QRT) first reported a position in CAH in Q2 2018 and has held it in 20 quarters since. The position peaked at $239M in Q2 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,012,309 shares of Cardinal Health worth $214M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 34,826 Cardinal Health shares in Q1 2026, an estimated $7.5M.
  • Cardinal Health made up 0.24% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #85 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cardinal Health in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Cardinal Health position peaked at $239M in Q2 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.